Transcat, Inc. (NASDAQ:TRNS) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 13.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 425,378 shares of the scientific and technical instruments company's stock after purchasing an additional 49,828 shares during the period. Vanguard Group Inc. owned 4.82% of Transcat worth $41,674,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. American Century Companies Inc. boosted its holdings in shares of Transcat by 23.1% in the 3rd quarter. American Century Companies Inc. now owns 3,660 shares of the scientific and technical instruments company's stock valued at $359,000 after buying an additional 687 shares in the last quarter. Deutsche Bank AG boosted its stake in Transcat by 13.2% in the third quarter. Deutsche Bank AG now owns 4,405 shares of the scientific and technical instruments company's stock valued at $432,000 after acquiring an additional 512 shares in the last quarter. Comerica Bank purchased a new position in Transcat in the third quarter worth $5,221,000. Diversified Trust Co acquired a new position in shares of Transcat during the third quarter worth $229,000. Finally, High Falls Advisors Inc lifted its holdings in shares of Transcat by 54.6% during the 3rd quarter. High Falls Advisors Inc now owns 6,915 shares of the scientific and technical instruments company's stock valued at $677,000 after purchasing an additional 2,443 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

TRNS has been the topic of several research analyst reports. HC Wainwright boosted their target price on Transcat from $108.00 to $124.00 and gave the stock a "buy" rating in a research note on Wednesday, January 31st. TheStreet upgraded shares of Transcat from a "c+" rating to a "b" rating in a report on Wednesday, January 31st.

Insider Buying and Selling at Transcat

In related news, Director Charles P. Hadeed sold 700 shares of the firm's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $113.00, for a total transaction of $79,100.00. Following the completion of the transaction, the director now owns 22,678 shares of the company's stock, valued at $2,562,614. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CEO Lee D. Rudow sold 5,000 shares of the firm's stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total transaction of $556,500.00. Following the sale, the chief executive officer now owns 108,478 shares of the company's stock, valued at approximately $12,073,601.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles P. Hadeed sold 700 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $113.00, for a total transaction of $79,100.00. Following the completion of the transaction, the director now owns 22,678 shares of the company's stock, valued at $2,562,614. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,073 shares of company stock worth $900,023. Company insiders own 4.20% of the company's stock.

Transcat Stock Performance

TRNS traded down $1.88 on Wednesday, reaching $110.15. 53,554 shares of the stock were exchanged, compared to its average volume of 37,236. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The company's 50-day moving average price is $108.84 and its 200 day moving average price is $101.40. The firm has a market capitalization of $972.62 million, a PE ratio of 84.02 and a beta of 0.59. Transcat, Inc. has a fifty-two week low of $74.89 and a fifty-two week high of $115.41.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The firm had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. As a group, sell-side analysts forecast that Transcat, Inc. will post 1.36 EPS for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.